Skip to content

Clinical trials

Urinary Bladder, Neurogenic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder, Neurogenic Country / region: United States Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20074
20082
20092
20112
20122
20131
20142
20152
20162
20173
20187
20197
20207
20217
20224
20237
20244
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Recruiting14
Active, not recruiting8
Not yet recruiting6
Terminated6
Unknown status5
Enrolling by invitation2
Withdrawn2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medstar Health Research Institute8
The Methodist Hospital Research Institute6
Spinal Singularity4
The University of Texas Health Science Center, Houston4
University of Louisville4
VA Office of Research and Development4
University of Michigan3
Boehringer Ingelheim2
Christopher Cooper2
Hollister Incorporated2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder, Neurogenic81
Spinal Cord Injuries29
Urinary Bladder, Overactive13
Urinary Tract Infections12
Urinary Retention11
Multiple Sclerosis9
Urinary Incontinence9
Urinary Incontinence, Urge7
Lower Urinary Tract Symptoms5
Spinal Dysraphism5

Trials

Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.